Announcements

View Bioporto newswire announcements.

Presentations

Recent investor presentations.

Annual Reports

View Bioporto Annual Reports.

Key Figures

Annual key figures.

Financial Calendar

Key dates on the financial calendar.

General Meetings

Details about the Annual General Meeting (AGM) and Extraordinary General Meeting (EGM).

BioPorto is listed on the NASDAQ Copenhagen stock exchange. [CPH: BIOPOR]

 

To BioPorto, openness and transparency are essential in maintaining good relations with investors. We aim to give the market open, accurate information about the company’s operations, strategy and results with a view to ensuring fair pricing of our shares and to contribute to ensuring good corporate governance.

All stakeholders should have fast, equal access to important information about BioPorto’s development and growth. One of the ways this is accomplished is by publicizing in-house knowledge in company announcements to Nasdaq Copenhagen, which are subsequently made available on this website (bioporto.com).

Investors and other interested parties can sign up for notification of published company announcements, newsletters, and other material by contacting Investor Relations to request access. Other publicized information, including general corporate and investor presentations, are made available to the general public on this website.

BioPorto uses quiet periods prior to the publication of annual and quarterly reports. In quiet periods no investor meetings are held. Relevant dates for quiet periods are listed in the financial calendar.

To ensure an efficient, expedient dialog with our shareholders, BioPorto encourages its shareholders to let their shareholding be registered and to participate in annual general meetings. The Investor Relations department is also responsible for ensuring that information from our investor-stakeholders is passed on to the management and the board of directors.

Learn more about the highly experienced leadership at BioPorto here: About BioPorto

Investor contacts:

Ole Larsen, CFO

Peter Mørch Eriksen, CEO

Tel.: +45 4529 0000

investor@bioporto.com